We have located links that may give you full text access.
English Abstract
Journal Article
[Total mesorectal excison and colonic-J-pouch-anal anastomosis in the therapy of low rectal carcinoma--results in 116 patients].
Zentralblatt Für Chirurgie 2002 September
BACKGROUND: Total mesorectal excision with coloanal anastomosis has been accepted as standard therapy of low rectal carcinoma. Interposition of colonic J-pouch improved the functional results and was associated with better postoperative quality of life. In this study our own results are evaluated.
METHODS: Between 1. 7. 1999 and 30. 6. 2001 116 patients underwent total mesorectal excision with coloanal anastomosis and colonic J-pouch interposition. Thirty-eight patients (32.9 %) with uT3-carcinoma received preoperative adjuvant short-time irradiation with 5 x 5 Gy and seven patients (6.0 %) with local non resectable cancer conventional radiochemotherapy with 50.4 Gy. A protective stoma was constructed in 56 patients (48.3 %). Six patients (5.2 %) received secondary stoma due to anastomotic complications.
RESULTS: A clinically relevant insufficiency of the anastomosis occurred in eight patients (6.9 %). Three patients needed a secondary laparotomy for local peritonitis. Fecal diversion was constructed secondarily in four patients due to pouchvaginal fistula and in one patient for ischiorectal abscess one year after the first operation. Six patients revealed small fistulas in the radiological examination without clinical consequences. Five patients with primary fecal diversion showed pouchvaginal fistulas. The over-all anastomotic complication rate was 16.4 %. The follow-up demonstrated already in the first year after surgery good functional results with satisfying anorectal continence. Only nine patients complained of intermittent incontinence for solid stool. No patient needed a definitive stoma due to anastomotic complications. One patient developed a small anastomotic tumor recurrence one year after surgery. He could be cured by abdomino-perineal excision.
CONCLUSIONS: Our results confirm the importance of total mesorectal excision as standard therapy for low rectal carcinoma. Good functional results can be obtained already in the early postoperative period by colonic J-pouch interposition.
METHODS: Between 1. 7. 1999 and 30. 6. 2001 116 patients underwent total mesorectal excision with coloanal anastomosis and colonic J-pouch interposition. Thirty-eight patients (32.9 %) with uT3-carcinoma received preoperative adjuvant short-time irradiation with 5 x 5 Gy and seven patients (6.0 %) with local non resectable cancer conventional radiochemotherapy with 50.4 Gy. A protective stoma was constructed in 56 patients (48.3 %). Six patients (5.2 %) received secondary stoma due to anastomotic complications.
RESULTS: A clinically relevant insufficiency of the anastomosis occurred in eight patients (6.9 %). Three patients needed a secondary laparotomy for local peritonitis. Fecal diversion was constructed secondarily in four patients due to pouchvaginal fistula and in one patient for ischiorectal abscess one year after the first operation. Six patients revealed small fistulas in the radiological examination without clinical consequences. Five patients with primary fecal diversion showed pouchvaginal fistulas. The over-all anastomotic complication rate was 16.4 %. The follow-up demonstrated already in the first year after surgery good functional results with satisfying anorectal continence. Only nine patients complained of intermittent incontinence for solid stool. No patient needed a definitive stoma due to anastomotic complications. One patient developed a small anastomotic tumor recurrence one year after surgery. He could be cured by abdomino-perineal excision.
CONCLUSIONS: Our results confirm the importance of total mesorectal excision as standard therapy for low rectal carcinoma. Good functional results can be obtained already in the early postoperative period by colonic J-pouch interposition.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app